---
schema_version: "secwatch.filing_event.v1"
accession: "0000920148-26-000205"
form_type: "8-K"
ticker: "LH"
cik: "0000920148"
company_name: "LABCORP HOLDINGS INC."
filed_at: "2026-09-22T20:43:38+00:00"
generated_at: "2026-09-22T20:44:20.521500+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Labcorp reaffirms 2026-29 outlook and flags CMS PAMA rate cuts

## Summary
- CMS released preliminary Clinical Laboratory Fee Schedule rates for 2027-2029 under PAMA on Sept 21, 2026.
- Labcorp says rates are based on non-representative data and would impose steep annual payment cuts threatening patient access.
- Reaffirms 2026-29 outlook: 5-8% CAGR revenue, 75-150 bps adjusted operating margin expansion by end of 2029.
- Reaffirms 8.5-11.5% CAGR adjusted EPS growth and free cash flow growth in line with adjusted earnings.
- Expects to provide 2027 guidance impact in February 2027; continues to support bipartisan RESULTS Act.

## SEC filing metadata
- accession: 0000920148-26-000205
- form_type: 8-K
- ticker: LH
- cik: 0000920148
- company_name: LABCORP HOLDINGS INC.
- filed_at: 2026-09-22T20:43:38+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/920148/000092014826000205/0000920148-26-000205-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/920148/000092014826000205/lh-20260922.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000920148-26-000205
- JSON: https://secwatch.observer/filing/0000920148-26-000205.json
- Plain text: https://secwatch.observer/filing/0000920148-26-000205.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.